Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 1
1962 2
1964 1
1965 1
1967 1
1968 3
1969 1
1970 1
1971 2
1973 3
1974 5
1975 4
1976 6
1977 2
1978 2
1979 4
1980 4
1981 4
1982 6
1983 1
1984 9
1985 9
1986 8
1987 17
1988 7
1989 5
1990 11
1991 13
1992 10
1993 6
1994 12
1995 13
1996 9
1997 24
1998 39
1999 27
2000 51
2001 51
2002 48
2003 61
2004 55
2005 73
2006 91
2007 111
2008 151
2009 162
2010 195
2011 200
2012 253
2013 305
2014 281
2015 276
2016 281
2017 293
2018 314
2019 271
2020 279
2021 314
2022 248
2023 248
2024 248
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,590 results

Results by year

Filters applied: . Clear all
Page 1
Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast Cancer.
Cortés J, Kim SB, Chung WP, Im SA, Park YH, Hegg R, Kim MH, Tseng LM, Petry V, Chung CF, Iwata H, Hamilton E, Curigliano G, Xu B, Huang CS, Kim JH, Chiu JWY, Pedrini JL, Lee C, Liu Y, Cathcart J, Bako E, Verma S, Hurvitz SA; DESTINY-Breast03 Trial Investigators. Cortés J, et al. Among authors: kim mh. N Engl J Med. 2022 Mar 24;386(12):1143-1154. doi: 10.1056/NEJMoa2115022. N Engl J Med. 2022. PMID: 35320644 Clinical Trial.
Pembrolizumab Plus Chemotherapy Followed by Pembrolizumab in Patients With Early Triple-Negative Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial.
Takahashi M, Cortés J, Dent R, Pusztai L, McArthur H, Kümmel S, Denkert C, Park YH, Im SA, Ahn JH, Mukai H, Huang CS, Chen SC, Kim MH, Jia L, Li XT, Tryfonidis K, Karantza V, Iwata H, Schmid P. Takahashi M, et al. Among authors: kim mh. JAMA Netw Open. 2023 Nov 1;6(11):e2342107. doi: 10.1001/jamanetworkopen.2023.42107. JAMA Netw Open. 2023. PMID: 37966841 Free PMC article. Clinical Trial.
The secreted protein Amuc_1409 from Akkermansia muciniphila improves gut health through intestinal stem cell regulation.
Kang EJ, Kim JH, Kim YE, Lee H, Jung KB, Chang DH, Lee Y, Park S, Lee EY, Lee EJ, Kang HB, Rhyoo MY, Seo S, Park S, Huh Y, Go J, Choi JH, Choi YK, Lee IB, Choi DH, Seo YJ, Noh JR, Kim KS, Hwang JH, Jeong JS, Kwon HJ, Yoo HM, Son MY, Kim YG, Lee DH, Kim TY, Kwon HJ, Kim MH, Kim BC, Kim YH, Kang D, Lee CH. Kang EJ, et al. Among authors: kim mh. Nat Commun. 2024 Apr 6;15(1):2983. doi: 10.1038/s41467-024-47275-8. Nat Commun. 2024. PMID: 38582860 Free PMC article.
Trastuzumab plus FOLFOX for HER2-positive biliary tract cancer refractory to gemcitabine and cisplatin: a multi-institutional phase 2 trial of the Korean Cancer Study Group (KCSG-HB19-14).
Lee CK, Chon HJ, Cheon J, Lee MA, Im HS, Jang JS, Kim MH, Park S, Kang B, Hong M, Kim JW, Park HS, Kang MJ, Park YN, Choi HJ. Lee CK, et al. Among authors: kim mh. Lancet Gastroenterol Hepatol. 2023 Jan;8(1):56-65. doi: 10.1016/S2468-1253(22)00335-1. Epub 2022 Oct 31. Lancet Gastroenterol Hepatol. 2023. PMID: 36328033 Clinical Trial.
Dissemination of pathogenic bacteria is reinforced by a MARTX toxin effector duet.
Choi S, Lee Y, Park S, Jang SY, Park J, Oh DW, Kim SM, Kim TH, Lee GS, Cho C, Kim BS, Lee D, Kim EH, Cheong HK, Moon JH, Song JJ, Hwang J, Kim MH. Choi S, et al. Among authors: kim mh. Nat Commun. 2024 Jul 23;15(1):6218. doi: 10.1038/s41467-024-50650-0. Nat Commun. 2024. PMID: 39043696 Free PMC article.
A comparison of treatment response to biologics in asthma-COPD overlap and pure asthma: Findings from the PRISM study.
Shim JS, Kim H, Kwon JW, Park SY, Kim S, Kim BK, Nam YH, Yang MS, Kim MY, Kim SH, Lee BJ, Lee T, Kim SH, Park SY, Cho YJ, Park CS, Jung JW, Park HK, Kim JH, Choi JH, Moon JY, Adcock I, Chung KF, Kim MH, Kim TB; Precision Intervention in Severe Asthma (PRISM) study investigatorsa. Shim JS, et al. Among authors: kim mh. World Allergy Organ J. 2023 Dec 12;16(12):100848. doi: 10.1016/j.waojou.2023.100848. eCollection 2023 Dec. World Allergy Organ J. 2023. PMID: 38093952 Free PMC article.
Role of Leptin in the Digestive System.
Kim MH, Kim H. Kim MH, et al. Front Pharmacol. 2021 Apr 12;12:660040. doi: 10.3389/fphar.2021.660040. eCollection 2021. Front Pharmacol. 2021. PMID: 33935782 Free PMC article. Review.
Bacterial Etiology in Subacute Cough.
Moon JY, Lee H, Kim MH, Song WJ, Lee SM, Kim SH, Kim SH, Lee BJ, Yoon HJ, Kim SH; on the behalf of Work Group for Chronic Cough, the Korean Academy of Asthma, Allergy and Clinical Immunology. Moon JY, et al. Among authors: kim mh. Allergy Asthma Immunol Res. 2023 Sep;15(5):673-681. doi: 10.4168/aair.2023.15.5.673. Epub 2023 Apr 26. Allergy Asthma Immunol Res. 2023. PMID: 37153983 Free PMC article.
Implication of Cluster Analysis in Childhood Asthma.
Kim MH, Kim TB. Kim MH, et al. Allergy Asthma Immunol Res. 2021 Jan;13(1):1-4. doi: 10.4168/aair.2021.13.1.1. Allergy Asthma Immunol Res. 2021. PMID: 33191672 Free PMC article. No abstract available.
4,590 results